Industry: Chemical & Material
Published Date: 2025-02-15
Pages: 77 Pages
Report ld: 3948469
Request Sample
Customized Report
The global Deslanoside API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Deslanoside is a cardiac glycoside used to treat congestive heart failure and supraventricular arrhythmias due to reentry mechanisms, and to control ventricular rate in the treatment of chronic atrial fibrillation. In this report, due to the relatively small number of Deslanoside manufacturers, we include Deslanoside for APIs and reagents.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Deslanoside API market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Deslanoside API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales and revenue of Deslanoside API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.
Chapter 3: Detailed analysis of Deslanoside API manufacturers competitive landscape, sales, revenue, price, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Region analysis by company, by customer, by Type, by Application, sales, revenue, and price for each segment,
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Deslanoside API revenue, gross margin, and recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Sales channels analysis
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Deslanoside API Product Scope
1.2 Deslanoside API by Type
1.2.1 Global Deslanoside API Sales by Type (2020 & 2024 & 2031)
1.2.2 Purity Above 99%
1.2.3 Purity Above 98%
1.2.4 Others
1.3 Deslanoside API by Application
1.3.1 Global Deslanoside API Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Pharmaceutical Factory
1.3.3 Research Institute
1.4 Global Deslanoside API Market Estimates and Forecasts (2020-2031)
1.4.1 Global Deslanoside API Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Deslanoside API Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Deslanoside API Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Deslanoside API Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Deslanoside API Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Deslanoside API Sales Market Share by Region (2020-2025)
2.2.2 Global Deslanoside API Revenue Market Share by Region (2020-2025)
2.3 Global Deslanoside API Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Deslanoside API Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Deslanoside API Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Deslanoside API Market Size and Prospective (2020-2031)
2.4.2 Europe Deslanoside API Market Size and Prospective (2020-2031)
2.4.3 China Deslanoside API Market Size and Prospective (2020-2031)
2.4.4 Japan Deslanoside API Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Deslanoside API Historic Market Review by Type (2020-2025)
3.1.1 Global Deslanoside API Sales by Type (2020-2025)
3.1.2 Global Deslanoside API Revenue by Type (2020-2025)
3.1.3 Global Deslanoside API Price by Type (2020-2025)
3.2 Global Deslanoside API Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Deslanoside API Sales Forecast by Type (2026-2031)
3.2.2 Global Deslanoside API Revenue Forecast by Type (2026-2031)
3.2.3 Global Deslanoside API Price Forecast by Type (2026-2031)
3.3 Different Types Deslanoside API Representative Players
4 Global Market Size by Application
4.1 Global Deslanoside API Historic Market Review by Application (2020-2025)
4.1.1 Global Deslanoside API Sales by Application (2020-2025)
4.1.2 Global Deslanoside API Revenue by Application (2020-2025)
4.1.3 Global Deslanoside API Price by Application (2020-2025)
4.2 Global Deslanoside API Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Deslanoside API Sales Forecast by Application (2026-2031)
4.2.2 Global Deslanoside API Revenue Forecast by Application (2026-2031)
4.2.3 Global Deslanoside API Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Deslanoside API Application
5 Competition Landscape by Players
5.1 Global Deslanoside API Sales by Players (2020-2025)
5.2 Global Top Deslanoside API Players by Revenue (2020-2025)
5.3 Global Deslanoside API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Deslanoside API as of 2024)
5.4 Global Deslanoside API Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Deslanoside API, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Deslanoside API, Product Type & Application
5.7 Global Key Manufacturers of Deslanoside API, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Deslanoside API Sales by Company
6.1.1.1 North America Deslanoside API Sales by Company (2020-2025)
6.1.1.2 North America Deslanoside API Revenue by Company (2020-2025)
6.1.2 North America Deslanoside API Sales Breakdown by Type (2020-2025)
6.1.3 North America Deslanoside API Sales Breakdown by Application (2020-2025)
6.1.4 North America Deslanoside API Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Deslanoside API Sales by Company
6.2.1.1 Europe Deslanoside API Sales by Company (2020-2025)
6.2.1.2 Europe Deslanoside API Revenue by Company (2020-2025)
6.2.2 Europe Deslanoside API Sales Breakdown by Type (2020-2025)
6.2.3 Europe Deslanoside API Sales Breakdown by Application (2020-2025)
6.2.4 Europe Deslanoside API Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Deslanoside API Sales by Company
6.3.1.1 China Deslanoside API Sales by Company (2020-2025)
6.3.1.2 China Deslanoside API Revenue by Company (2020-2025)
6.3.2 China Deslanoside API Sales Breakdown by Type (2020-2025)
6.3.3 China Deslanoside API Sales Breakdown by Application (2020-2025)
6.3.4 China Deslanoside API Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Deslanoside API Sales by Company
6.4.1.1 Japan Deslanoside API Sales by Company (2020-2025)
6.4.1.2 Japan Deslanoside API Revenue by Company (2020-2025)
6.4.2 Japan Deslanoside API Sales Breakdown by Type (2020-2025)
6.4.3 Japan Deslanoside API Sales Breakdown by Application (2020-2025)
6.4.4 Japan Deslanoside API Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Beijing lingbao
7.1.1 Beijing lingbao Company Information
7.1.2 Beijing lingbao Business Overview
7.1.3 Beijing lingbao Deslanoside API Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Beijing lingbao Deslanoside API Products Offered
7.1.5 Beijing lingbao Recent Development
7.2 Green Stone
7.2.1 Green Stone Company Information
7.2.2 Green Stone Business Overview
7.2.3 Green Stone Deslanoside API Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Green Stone Deslanoside API Products Offered
7.2.5 Green Stone Recent Development
7.3 Swapnroop Drugs And Pharmaceuticals
7.3.1 Swapnroop Drugs And Pharmaceuticals Company Information
7.3.2 Swapnroop Drugs And Pharmaceuticals Business Overview
7.3.3 Swapnroop Drugs And Pharmaceuticals Deslanoside API Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Swapnroop Drugs And Pharmaceuticals Deslanoside API Products Offered
7.3.5 Swapnroop Drugs And Pharmaceuticals Recent Development
7.4 Push Bio
7.4.1 Push Bio Company Information
7.4.2 Push Bio Business Overview
7.4.3 Push Bio Deslanoside API Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Push Bio Deslanoside API Products Offered
7.4.5 Push Bio Recent Development
7.5 Sigma-Aldrich
7.5.1 Sigma-Aldrich Company Information
7.5.2 Sigma-Aldrich Business Overview
7.5.3 Sigma-Aldrich Deslanoside API Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Sigma-Aldrich Deslanoside API Products Offered
7.5.5 Sigma-Aldrich Recent Development
7.6 Carbosynth
7.6.1 Carbosynth Company Information
7.6.2 Carbosynth Business Overview
7.6.3 Carbosynth Deslanoside API Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Carbosynth Deslanoside API Products Offered
7.6.5 Carbosynth Recent Development
7.7 Bolise Co., Ltd.
7.7.1 Bolise Co., Ltd. Company Information
7.7.2 Bolise Co., Ltd. Business Overview
7.7.3 Bolise Co., Ltd. Deslanoside API Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Bolise Co., Ltd. Deslanoside API Products Offered
7.7.5 Bolise Co., Ltd. Recent Development
7.8 Shanghai Yuanye
7.8.1 Shanghai Yuanye Company Information
7.8.2 Shanghai Yuanye Business Overview
7.8.3 Shanghai Yuanye Deslanoside API Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Shanghai Yuanye Deslanoside API Products Offered
7.8.5 Shanghai Yuanye Recent Development
8 Deslanoside API Manufacturing Cost Analysis
8.1 Deslanoside API Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Deslanoside API
8.4 Deslanoside API Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Deslanoside API Distributors List
9.3 Deslanoside API Customers
10 Deslanoside API Market Dynamics
10.1 Deslanoside API Industry Trends
10.2 Deslanoside API Market Drivers
10.3 Deslanoside API Market Challenges
10.4 Deslanoside API Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Deslanoside API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 131
USD 3950.00
(Single User License)
The global Deslanoside API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 134
USD 2900.00
(Single User License)
The global Deslanoside API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-22
Pages: 150
USD 4900.00
(Single User License)
The global market for Deslanoside API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 100
USD 3950.00
(Single User License)
The global market for Deslanoside API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 93
USD 2900.00
(Single User License)
Deslanoside is a cardiac glycoside used to treat congestive heart failure and supraventricular arrhythmias due to reentry mechanisms, and to control ventricular rate in the treatment of chronic atrial fibrillation. In this report, due to the relatively small number of Deslanoside manufacturers, we include Deslanoside for APIs and reagents.
Published Date: 2024-04-11
Pages: 90
USD 4900.00
(Single User License)
Deslanoside is a cardiac glycoside used to treat congestive heart failure and supraventricular arrhythmias due to reentry mechanisms, and to control ventricular rate in the treatment of chronic atrial fibrillation. In this report, due to the relatively small number of Deslanoside manufacturers, we include Deslanoside for APIs and reagents.
Published Date: 2024-01-17
Pages: 87
USD 2900.00
(Single User License)
Deslanoside is a cardiac glycoside used to treat congestive heart failure and supraventricular arrhythmias due to reentry mechanisms, and to control ventricular rate in the treatment of chronic atrial fibrillation. In this report, due to the relatively small number of Deslanoside manufacturers, we include Deslanoside for APIs and reagents.
Published Date: 2024-01-06
Pages: 92
USD 3950.00
(Single User License)
The global market for Deslanoside API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 131
The global Deslanoside API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 134
The global Deslanoside API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-22
Pages: 150
The global market for Deslanoside API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 100
The global market for Deslanoside API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 93
Deslanoside is a cardiac glycoside used to treat congestive heart failure and supraventricular arrhythmias due to reentry mechanisms, and to control ventricular rate in the treatment of chronic atrial fibrillation. In this report, due to the relatively small number of Deslanoside manufacturers, we include Deslanoside for APIs and reagents.
Published: 2024-04-11
Pages: 90
Deslanoside is a cardiac glycoside used to treat congestive heart failure and supraventricular arrhythmias due to reentry mechanisms, and to control ventricular rate in the treatment of chronic atrial fibrillation. In this report, due to the relatively small number of Deslanoside manufacturers, we include Deslanoside for APIs and reagents.
Published: 2024-01-17
Pages: 87
Deslanoside is a cardiac glycoside used to treat congestive heart failure and supraventricular arrhythmias due to reentry mechanisms, and to control ventricular rate in the treatment of chronic atrial fibrillation. In this report, due to the relatively small number of Deslanoside manufacturers, we include Deslanoside for APIs and reagents.
Published: 2024-01-06
Pages: 92
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now